Circulating microparticles: challenges and perspectives of flow cytometric assessment

Circulating blood microparticles are likely to play a significant role as messengers of biological information. Their accurate quantification and characterisation is challenging and needs to be carefully designed with preferable usage of fresh minimally-processed blood samples. Utilisation of flow cytometers specifically designed for analysis of small-size particles is likely to provide considerable methodological advantages and should be the preferable option. This viewpoint manuscript provides a critical summary of the key methodological aspects of microparticle analysis.

[1]  G. Chironi,et al.  Shear Stress Regulates Endothelial Microparticle Release , 2013, Circulation research.

[2]  Penelope V Dalla,et al.  Breast Cancer-Derived Microparticles Display Tissue Selectivity in the Transfer of Resistance Proteins to Cells , 2013, PloS one.

[3]  Leo M. Carlin,et al.  Nr4a1-Dependent Ly6Clow Monocytes Monitor Endothelial Cells and Orchestrate Their Disposal , 2013, Cell.

[4]  A. Siegbahn,et al.  Evaluation of microparticles in whole blood by multicolour flow cytometry assay , 2013, Scandinavian journal of clinical and laboratory investigation.

[5]  S. Manzano-Fernández,et al.  Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. , 2013, Atherosclerosis.

[6]  W. Chandler.  Microparticle counts in platelet-rich and platelet-free plasma, effect of centrifugation and sample-processing protocols , 2012, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[7]  C. Hillery,et al.  Phosphatidylethanolamine is externalized at the surface of microparticles. , 2012, Biochimica et biophysica acta.

[8]  N. Klein,et al.  Endothelial injury in childhood stroke with cerebral arteriopathy , 2012, Neurology.

[9]  R. Andriantsitohaina,et al.  Circulating microparticles from patients with obstructive sleep apnea enhance vascular contraction: mandatory role of the endothelium. , 2012, The American journal of pathology.

[10]  Ramaroson Andriantsitohaina,et al.  Microparticle release in remote ischemic conditioning mechanism. , 2012, American journal of physiology. Heart and circulatory physiology.

[11]  J. Hansen,et al.  Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles. , 2012, Thrombosis research.

[12]  J. Low,et al.  Low concentration detergent sclerosants induce platelet activation but inhibit aggregation due to suppression of GPIIb/IIIa activation in vitro. , 2012, Thrombosis research.

[13]  B. Brenner,et al.  Characterization of negatively charged phospholipids and cell origin of microparticles in women with gestational vascular complications. , 2012, Thrombosis research.

[14]  A. Artoni,et al.  Residual platelets are the main determinants of microparticles count in frozen-thawed plasma. , 2012, Thrombosis research.

[15]  Yongbo Huang,et al.  Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis. , 2012, Thrombosis research.

[16]  D. McIntire,et al.  Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period. , 2012, American journal of obstetrics and gynecology.

[17]  D. Franchimont,et al.  CD47Low Status on CD4 Effectors Is Necessary for the Contraction/Resolution of the Immune Response in Humans and Mice , 2012, PloS one.

[18]  S. Fieuws,et al.  Circulating apoptotic endothelial cells and apoptotic endothelial microparticles independently predict the presence of cardiac allograft vasculopathy. , 2012, Journal of the American College of Cardiology.

[19]  R. Neubig,et al.  Increased CD39 Nucleotidase Activity on Microparticles from Patients with Idiopathic Pulmonary Arterial Hypertension , 2012, PloS one.

[20]  T. Renné,et al.  Platelet‐ and erythrocyte‐derived microparticles trigger thrombin generation via factor XIIa , 2012, Journal of thrombosis and haemostasis : JTH.

[21]  Yu Luo,et al.  Plasma Endothelial Microparticles and Their Correlation With the Presence of Hypertension and Arterial Stiffness in Patients With Type 2 Diabetes , 2012, Journal of clinical hypertension.

[22]  V. Paradis,et al.  Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. , 2012, Gastroenterology.

[23]  H. Haller,et al.  Microparticle generation and leucocyte death in Shiga toxin-mediated HUS. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  F. Santilli,et al.  A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction. , 2012, Journal of immunological methods.

[25]  E. Orenes-Piñero,et al.  An innovative flow cytometric approach for small-size platelet microparticles: Influence of calcium , 2012, Thrombosis and Haemostasis.

[26]  E. Vicari,et al.  Dysfunction of the endothelial‐platelet pathway in patients with erectile dysfunction before and after daily treatment with tadalafil , 2012, Andrologia.

[27]  J. Heit,et al.  Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not. , 2012, Surgery.

[28]  W. Kozubski,et al.  Reactive leptin resistance and the profile of platelet activation in acute ischaemic stroke patients , 2012, Thrombosis and Haemostasis.

[29]  M. Bruzelius,et al.  Studies of microparticles in patients with the antiphospholipid syndrome (APS) , 2012, Lupus.

[30]  R. Nieuwland,et al.  Climacteric Lowers Plasma Levels of Platelet-Derived Microparticles: A Pilot Study in Pre- versus Postmenopausal Women , 2012, Acta Haematologica.

[31]  J. Usherwood,et al.  Microparticle formation after co‐culture of human whole blood and umbilical artery in a novel in vitro model of flow , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[32]  G. London,et al.  Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  M. Maier‐Redelsperger,et al.  The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles , 2012, Thrombosis and Haemostasis.

[34]  J. Roh,et al.  Circulating CD62E+ Microparticles and Cardiovascular Outcomes , 2012, PloS one.

[35]  S. Thom,et al.  Microparticle production, neutrophil activation, and intravascular bubbles following open-water SCUBA diving. , 2012, Journal of applied physiology.

[36]  G. Mourey,et al.  Correlation between platelet-derived microparticle enumeration by flow cytometry and phospholipid-dependent procoagulant activity in microparticles: The centrifugation step matters! , 2012, Thrombosis and Haemostasis.

[37]  M. Lederman,et al.  Increased Platelet and Microparticle Activation in HIV Infection: Upregulation of P-Selectin and Tissue Factor Expression , 2012, Journal of acquired immune deficiency syndromes.

[38]  L. Truedsson,et al.  Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. , 2012, Arthritis and rheumatism.

[39]  R Lacroix,et al.  Impact of pre‐analytical parameters on the measurement of circulating microparticles: towards standardization of protocol , 2012, Journal of thrombosis and haemostasis : JTH.

[40]  Christian Jung,et al.  Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. , 2012, Atherosclerosis.

[41]  Wei Xie,et al.  Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis. , 2012, Leukemia research.

[42]  A. Taylan,et al.  Evaluation of Circulating Endothelial and Platelet Microparticles in Men with Ankylosing Spondylitis , 2012, The Journal of Rheumatology.

[43]  C. Gao,et al.  Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome , 2012, Thrombosis and Haemostasis.

[44]  H. Wallen,et al.  Platelet-derived microparticles during and after acute coronary syndrome , 2012, Thrombosis and Haemostasis.

[45]  C. Vrints,et al.  Endothelial Microparticles (EMP) for the Assessment of Endothelial Function: An In Vitro and In Vivo Study on Possible Interference of Plasma Lipids , 2012, PloS one.

[46]  K. Sliwa,et al.  Circulating microparticles as indicators of peripartum cardiomyopathy. , 2012, European heart journal.

[47]  A. Enjeti,et al.  Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V Leiden. , 2012, Thrombosis research.

[48]  M. Vilardell‐Tarrés,et al.  Circulating Cell‐Derived Microparticles in Severe Preeclampsia and in Fetal Growth Restriction , 2012, American journal of reproductive immunology.

[49]  V. Miller,et al.  Methodology for isolation, identification and characterization of microvesicles in peripheral blood. , 2012, Journal of immunological methods.

[50]  T. Nawrot,et al.  Air pollution‐associated procoagulant changes: the role of circulating microvesicles , 2012, Journal of thrombosis and haemostasis : JTH.

[51]  N. Mackman,et al.  Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. , 2012, Thrombosis research.

[52]  D. Newby,et al.  Platelet activation in patients with peripheral vascular disease: reproducibility and comparability of platelet markers. , 2012, Thrombosis research.

[53]  B. Furie,et al.  Measurement of platelet microparticles. , 2012, Methods in molecular biology.

[54]  A. M. Leone,et al.  Differences in microparticle release in patients with acute coronary syndrome and stable angina. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[55]  N. Egberg,et al.  Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study. , 2012, Thrombosis research.

[56]  E. Stępień,et al.  Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation. , 2012, Archives of medical research.

[57]  R. Salomão,et al.  Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary artery disease. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[58]  M. Hayashi,et al.  Platelet activation and induction of tissue factor in acute and chronic atrial fibrillation: involvement of mononuclear cell-platelet interaction. , 2011, Thrombosis research.

[59]  J. Berg,et al.  Fluorescent particles in the antibody solution result in false TF‐ and CD14‐positive microparticles in flow cytometric analysis , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[60]  C. Cerletti,et al.  Epoprostenol inhibits human platelet-leukocyte mixed conjugate and platelet microparticle formation in whole blood. , 2011, Thrombosis research.

[61]  C. Bode,et al.  Circulating annexin V positive microparticles in patients after successful cardiopulmonary resuscitation , 2011, Critical care.

[62]  M. Macey,et al.  Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease. , 2011, Rheumatology.

[63]  C. Johnsen,et al.  Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. , 2011, Arthritis and rheumatism.

[64]  Plasma microparticles are not elevated in fresh plasma from patients with gynaecological malignancy--an observational study. , 2011, Gynecologic oncology.

[65]  J. Lovegrove,et al.  Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[66]  Circulating Cell‐Derived Microparticles in Women with Pregnancy Loss , 2011, American journal of reproductive immunology.

[67]  M. Papp,et al.  Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients , 2011, Thrombosis and Haemostasis.

[68]  R. Salomão,et al.  Imbalance between endothelial progenitors cells and microparticles in HIV-infected patients naive for antiretroviral therapy , 2011, AIDS.

[69]  A. Ganser,et al.  Evaluation of Tissue Factor Bearing Microparticles as Biomarkers in Allogeneic Stem-Cell Transplantation , 2011, Transplantation.

[70]  J. Thachil,et al.  The clinical and functional relevance of microparticles induced by activated protein C treatment in sepsis , 2011, Critical care.

[71]  Leila Kheirandish-Gozal,et al.  Circulating microparticles in children with sleep disordered breathing. , 2011, Chest.

[72]  K. Guire,et al.  Evaluation of Soluble P-Selectin as a Marker for the Diagnosis of Deep Venous Thrombosis , 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[73]  J. Mezey,et al.  Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. , 2011, American journal of respiratory and critical care medicine.

[74]  C. Wade,et al.  Decline in platelet microparticles contributes to reduced hemostatic potential of stored plasma. , 2011, Thrombosis research.

[75]  B. Rinner,et al.  Microparticles in newborn cord blood: slight elevation after normal delivery. , 2011, Thrombosis research.

[76]  R. Claus,et al.  Cell-derived microparticles promote coagulation after moderate exercise. , 2011, Medicine and science in sports and exercise.

[77]  F. Aubin,et al.  Increased levels of circulating endothelial-derived microparticles and small-size platelet-derived microparticles in psoriasis. , 2011, The Journal of investigative dermatology.

[78]  I. Katsikis,et al.  Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels. , 2011, European Journal of Endocrinology.

[79]  G. Lip,et al.  Circulating microparticles: new insights into the biochemical basis of microparticle release and activity , 2011, Basic Research in Cardiology.

[80]  J. Tait,et al.  A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer , 2011, Journal of thrombosis and haemostasis : JTH.

[81]  S. Sadallah,et al.  Microparticles (Ectosomes) Shed by Stored Human Platelets Downregulate Macrophages and Modify the Development of Dendritic Cells , 2011, The Journal of Immunology.

[82]  H. Wallen,et al.  Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease , 2011, Thrombosis and Haemostasis.

[83]  D. Schneider,et al.  Platelet‐white blood cell (WBC) interaction, WBC apoptosis, and procoagulant activity in stored red blood cells , 2011, Transfusion.

[84]  R. Andriantsitohaina,et al.  Nocturnal release of leukocyte-derived microparticles in males with obstructive sleep apnoea , 2011, European Respiratory Journal.

[85]  P. Simioni,et al.  Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. , 2011, Thrombosis research.

[86]  E. Reyna-Villasmil,et al.  Microparticulas endoteliales en preeclampsia y eclampsia , 2011 .

[87]  Jorly Mejia-Montilla,et al.  [Endothelial microparticles in preeclampsia and eclampsia]. , 2011, Medicina clinica.

[88]  L. Micó,et al.  Células endoteliales y micropartículas circulantes en pacientes portadores de anticuerpos antifosfolípidos , 2011 .

[89]  P. Théroux,et al.  Requirements for Membrane Attack Complex Formation and Anaphylatoxins Binding to Collagen-Activated Platelets , 2011, PloS one.

[90]  G. Nickenig,et al.  Circulating CD 31 1 / Annexin V 1 microparticles correlate with cardiovascular outcomes , 2011 .

[91]  Nizar M. Mhaidat,et al.  The putative diabetic plasma marker, soluble CD36, is non‐cleaved, non‐soluble and entirely associated with microparticles , 2011, Journal of thrombosis and haemostasis : JTH.

[92]  B. Ferry,et al.  Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. , 2011, Thrombosis research.

[93]  R. Nieuwland,et al.  Surveillance of megakaryocytic function by measurement of CD61‐exposing microparticles in allogeneic hematopoietic stem cell recipients , 2011, Clinical transplantation.

[94]  A. Mügge,et al.  Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy , 2011, Clinical Research in Cardiology.

[95]  R. Nieuwland,et al.  Clearance of platelet microparticles in vivo , 2011, Platelets.

[96]  O. Muller,et al.  Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel , 2011, Journal of Thrombosis and Thrombolysis.

[97]  G. E. Gilbert,et al.  Lactadherin functions as a probe for phosphatidylserine exposure and as an anticoagulant in the study of stored platelets , 2011, Vox sanguinis.

[98]  R. Nieuwland,et al.  Apheresis platelet concentrates contain platelet‐derived and endothelial cell‐derived microparticles , 2011, Vox sanguinis.

[99]  P. Pérez-Martínez,et al.  Mediterranean diet reduces endothelial damage and improves the regenerative capacity of endothelium. , 2011, The American journal of clinical nutrition.

[100]  E. Maurer-Spurej,et al.  Novel test for microparticles in platelet‐rich plasma and platelet concentrates using dynamic light scattering , 2011, Transfusion.

[101]  M. Macey,et al.  Flow cytometric analysis of microparticle phenotype and their role in thrombin generation , 2011, Cytometry. Part B, Clinical cytometry.

[102]  R. Bertina,et al.  Pre-analytical and analytical issues in the analysis of blood microparticles , 2010, Thrombosis and Haemostasis.

[103]  H. ten Cate,et al.  Elevated numbers and altered subsets of procoagulant microparticles in breast cancer patients using endocrine therapy. , 2010, Thrombosis research.

[104]  Lieberman,et al.  CD11b+ leukocyte microparticles are associated with high-risk angiographic lesions and recurrent cardiovascular events in acute coronary syndromes , 2011 .

[105]  V. Vila,et al.  [Circulating endothelial cells and microparticles in patients with antiphospholipid antibodies]. , 2011, Medicina clinica.

[106]  I. Dursun,et al.  Circulating endothelial microparticles in children with Henoch–Schönlein purpura; preliminary results , 2011, Rheumatology International.

[107]  A. Minagar,et al.  The effects of high dose interferon-β1a on plasma microparticles: Correlation with MRI parameters , 2011, Journal of Neuroinflammation.

[108]  C. Bode,et al.  Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension , 2011, Journal of Thrombosis and Thrombolysis.

[109]  M. Haubitz,et al.  Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing , 2010, Vascular health and risk management.

[110]  G. Lip,et al.  Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis , 2010, Journal of thrombosis and haemostasis : JTH.

[111]  R Lacroix,et al.  Standardization of platelet‐derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop , 2010, Journal of thrombosis and haemostasis : JTH.

[112]  Christian Weber,et al.  Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange , 2010, Circulation research.

[113]  D. Lewis,et al.  Flow cytometric analysis of circulating microparticles in plasma , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[114]  D. Connor,et al.  The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib , 2010, Thrombosis and Haemostasis.

[115]  C. Vrints,et al.  Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied. , 2010, Thrombosis research.

[116]  T H Oosterkamp,et al.  Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles , 2010, Journal of thrombosis and haemostasis : JTH.

[117]  R. Cardigan,et al.  Microparticle sizing by dynamic light scattering in fresh‐frozen plasma , 2009, Vox sanguinis.

[118]  J. Freyssinet,et al.  Centrifugation is a crucial step impacting microparticle measurement , 2009, Platelets.

[119]  L. Arnaud,et al.  Standardization of platelet‐derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? , 2009, Journal of thrombosis and haemostasis : JTH.

[120]  Mona D. Shah,et al.  Flow cytometric measurement of microparticles: Pitfalls and protocol modifications , 2008, Platelets.

[121]  L. Horstman,et al.  Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. , 2003, Thrombosis research.